Skip to content

Titanium Mesh Coated With Natural Hydroxyapatite Nanocrystals in Orbital Reconstruction

Evaluation of Titanium Mesh Coated With Natural Hydroxyapatite Nanocrystals in Orbital Reconstruction (Randomized Controlled Clinical Trial)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05437731
Enrollment
12
Registered
2022-06-29
Start date
2022-03-01
Completion date
2022-10-30
Last updated
2022-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orbital Deformity

Brief summary

Reconstruction of maxillofacial continuity defects has always been a challenging task for scientists and surgeons over the years. The main goal of the reconstruction of the maxillofacial region is to restore facial form, function, and full rehabilitation of occlusion and articulation. A refinement in surgical technique and methods of reconstruction has improved patients' quality of life. Aim of this study: Evaluation of titanium mesh coated with natural hydroxyapatite in orbital reconstruction.

Detailed description

Twelve patients having orbital defects will be selected. Six defects will be reconstructed using titanium mesh coated with natural hydroxyapatite nanocrystals (study group) and the other six will be treated with uncoated titanium mesh (control group). Patients will be evaluated clinically, then a radiographic follow-up will be performed immediately postoperatively and after three months to evaluate the bone density at the defect. Also, the coated and uncoated titanium mesh will be mechanically evaluated to compare the tensile strength of the two groups.

Interventions

OTHERCoated titanium mesh

patients will undergo repairing of defects or reconstruction using the titanium mesh coated with hydroxyapatite nanocrystals.

OTHERUncoated titanium mesh

patients will undergo reconstruction using the conventional uncoated titanium mesh.

Sponsors

Hams Hamed Abdelrahman
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* All patients requiring reconstruction of acquired orbital defects using titanium mesh. * Both genders with age group ranging from 18-60 years old. * Limited size defects according to Cordeiro and Santamaria. * Isolated unilateral or bilateral orbital fractures or combined with other facial fractures. * Orbital reconstruction after removal of benign pathological lesions.

Exclusion criteria

* Infected fracture sites. * Chronic systemic diseases such as uncontrolled diabetes, rheumatoid arthritis, metabolic bone disease, immunocompromised status etc. * Defects requiring soft tissue reconstruction. * Patients suffering from burns. * Patients suffering from carcinomas and sarcomas in the oral cavity.

Design outcomes

Primary

MeasureTime frameDescription
Change in wound healing criteriaafter 24-hours, one week, four weeks, and six weeksThe sutured wounds will be examined for signs and symptoms of infection. Yes: for presence of signs and sympotms No: for absence of signs and symptoms
Change in bone densityat baseline and 3 monthsAll patients will be radiographically examined immediately and 3 months postoperatively using multi-slice computerized tomography (CT) using OnDemand3D software

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026